GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in GH Research PLC as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −4 vs. Q2 2021
- Shares held
- 28.5M
- +917.8K (+3.3%) vs. Q2 2021
- Total value
- $625.2M
- +$31.5M (+5.3%) vs. Q2 2021
- New holders
- 7
- 8 more added
- Sold out
- 11
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 22 | $0 | 0.00% | +22 | New |
| Global Retirement Partners, LLC | 220 | $5.00K | 0.00% | +220 | New |
| AdvisorShares Investments LLC | 3,768 | $83.0K | 0.01% | +3,768 | New |
| Schonfeld Strategic Advisors LLC | 17,223 | $380.0K | 0.00% | +17,223 | New |
| Penserra Capital Management LLC | 25,366 | $559.0K | 0.01% | +25,366 | New |
| Geode Capital Management, LLC | 27,198 | $599.0K | 0.00% | +27,198 | New |
| Pinz Capital Management, LP | 38,408 | $847.0K | 0.38% | −30,092−43.9% | Reduced |
| Walleye Capital LLC | 40,748 | $899.0K | 0.03% | −44,352−52.1% | Reduced |
| Woodline Partners LP | 48,866 | $1.08M | 0.02% | −90,031−64.8% | Reduced |
| HealthCor Management, L.P. | 164,912 | $3.64M | 0.16% | −85,088−34.0% | Reduced |
| Logos Global Management LP | 324,333 | $6.44M | 0.46% | −400,000−55.2% | Reduced |
| Laurion Capital Management LP | 345,000 | $7.61M | 0.11% | −15,000−4.2% | Reduced |
| Pura Vida Investments, LLC | 380,045 | $8.38M | 0.63% | −19,955−5.0% | Reduced |
| Acuta Capital Partners, LLC | 393,250 | $8.68M | 3.09% | +243,250+162.2% | Added |
| Adage Capital Partners GP, L.L.C. | 400,000 | $8.82M | 0.02% | −65,000−14.0% | Reduced |
| Ghost Tree Capital, LLC | 400,000 | $8.82M | 2.91% | +400,000 | New |
| Deerfield Management Company, L.P. (Series C) | 405,416 | $8.94M | 0.17% | −150,000−27.0% | Reduced |
| Morgan Stanley | 424,260 | $9.36M | 0.00% | +222,532+110.3% | Added |
| TimesSquare Capital Management, LLC | 500,599 | $11.0M | 0.10% | +78,310+18.5% | Added |
| Avidity Partners Management LP | 560,000 | $12.4M | 0.31% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 608,123 | $13.1M | 0.53% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,013,399 | $22.4M | 0.78% | 00.0% | Unchanged |
| Verition Fund Management LLC | 1,263,124 | $27.9M | 0.42% | −75,000−5.6% | Reduced |
| Citadel Advisors LLC | 1,312,646 | $28.3M | 0.03% | +28,856+2.2% | Added |
| OrbiMed Advisors LLC | 1,428,666 | $31.5M | 0.35% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,642,296 | $36.2M | 4.65% | +366,465+28.7% | Added |
| RTW Investments, LP | 2,168,957 | $45.7M | 0.69% | 00.0% | Unchanged |
| FMR LLC | 2,283,964 | $50.4M | 0.00% | +922,270+67.7% | Added |
| Ra Capital Management, L.P. | 3,013,957 | $66.5M | 0.92% | +35,002+1.2% | Added |
| BVF Inc | 9,275,158 | $204.6M | 7.98% | +20.0% | Added |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −45,866−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −19,624−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,525−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −837−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −335−100.0% | Sold out |